Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
1.
Artigo em Inglês | MEDLINE | ID: mdl-22584914

RESUMO

PURPOSE: We used new criteria to elucidate the demographics of acute low-tone sensorineural hearing loss (ALHL) and tested the Chinese medicine Wu-Ling-San as a treatment for ALHL. PROCEDURES: We reviewed the medical records of patients with ALHL seen at the outpatient clinic of the Social Insurance Central General Hospital in Tokyo from April 2006 through August 2011. Patients were treated with an oral steroid, a diuretic, or Wu-Ling-San; alone or in combination. RESULTS: We identified 130 definite and 48 probable ALHL cases. The mean age and male-to-female ratio in probable cases were significantly higher than those in definite cases (p < 0.05). The steroid-Wu-Ling-San combination was significantly more effective (100% recovery) than the diuretic alone (59%), Wu-Ling-San alone (62%), or the steroid-diuretic combination (60%, p < 0.05). CONCLUSIONS: ALHL can develop in older patients more frequently than we expected. The steroid-Wu-Ling-San combination is a possible new treatment for ALHL.


Assuntos
Medicamentos de Ervas Chinesas/administração & dosagem , Perda Auditiva Neurossensorial/tratamento farmacológico , Medicina Tradicional Chinesa/métodos , Doença Aguda , Adulto , Distribuição por Idade , Idoso , Diuréticos Osmóticos/administração & dosagem , Sinergismo Farmacológico , Quimioterapia Combinada , Feminino , Glucocorticoides/administração & dosagem , Perda Auditiva Neurossensorial/epidemiologia , Humanos , Isossorbida/administração & dosagem , Masculino , Pessoa de Meia-Idade , Pacientes Ambulatoriais/estatística & dados numéricos , Prednisolona/administração & dosagem , Estudos Retrospectivos , Distribuição por Sexo , Resultado do Tratamento
2.
BJU Int ; 83(7): 810-1, 1999 May.
Artigo em Inglês | MEDLINE | ID: mdl-10368202

RESUMO

OBJECTIVE: To repeat a previous study on the use of a topical treatment for erectile failure using a vasoactive cream. PATIENTS AND METHODS: Fourteen patients with erectile failure who had previously responded to intracorporeal injection therapy were enrolled in a randomized placebo-controlled trial. They were given two topical applications, comprising either a cream containing aminophylline, isosorbide dinitrate and co-dergocrine mesylate, or a placebo cream of similar appearance containing no pharmacologically active ingredients. Each patient received 16 applications, eight of the active cream and eight placebo. The creams were applied alternatively on successive occasions and the results recorded. RESULTS: The active cream, applied on 77 occasions, resulted in three good and 13 partial erections. The placebo cream, applied on 76 occasions, yielded four good and 13 partial erections. CONCLUSIONS: We were unable to reproduce the successful results reported by others; in the present study the active cream performed no better than placebo.


Assuntos
Aminofilina/administração & dosagem , Mesilatos Ergoloides/administração & dosagem , Impotência Vasculogênica/tratamento farmacológico , Isossorbida/administração & dosagem , Nifedipino/administração & dosagem , Vasodilatadores/administração & dosagem , Adulto , Combinação de Medicamentos , Humanos , Masculino , Pessoa de Meia-Idade , Pomadas , Ereção Peniana/efeitos dos fármacos , Estudos Prospectivos
3.
Z Gesamte Inn Med ; 45(3): 71-6, 1990 Mar 01.
Artigo em Alemão | MEDLINE | ID: mdl-2186579

RESUMO

In 50 patients with chronic congestive heart failure (CCHF, III or IV class), aged 62.8 +/- 9.1 years, who were treated with digoxin (Dx) and furosemide (F) (investigation A), continuous 24-hour ecg registration was performed according to Holter. Next, this treatment was extended by two-week administration of nifedipine (N) or isosorbide dinitrate (S) (investigation B), followed by one-month addition of captopril (Cp) (investigation C). During the last two weeks Dx, F, N or Dx, F, S were administered with Cp being withdrawn (investigation D). At the end of each stage of the treatment ecg registration was repeated according to Holter. At the same time, during the investigation A there were performed determinations of blood serum sodium, potassium and digoxin concentrations, two-dimensional echocardiography and evaluation of submaximal exercise tolerance. In 96 per cent of patients with CCHF, treated with Dx and F, cardiac rhythm disturbances were found. In 53.3 per cent life-threatening ventricular arrhythmias occurred, including unstable ventricular tachycardia in 11.1 per cent of patients. Addition of N or S to the classical treatment did not decrease either patient number or amounts of cardiac rhythm disturbances in individual classes according to Lown. Also Cp did not affect numbers of patients with cardiac rhythm disturbances, but it decreased numbers of patients with life-threatening ventricular arrhythmias from 53.3 per cent to 28.9 per cent (from 24/45 to 13/45). At the same time, Cp significantly decreased numbers of ventricular arrhythmias in class 3 and 4a (p less than 0.05).(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Arritmias Cardíacas/tratamento farmacológico , Eletrocardiografia/efeitos dos fármacos , Insuficiência Cardíaca/tratamento farmacológico , Vasodilatadores/uso terapêutico , Adulto , Idoso , Idoso de 80 Anos ou mais , Fibrilação Atrial/tratamento farmacológico , Captopril/administração & dosagem , Débito Cardíaco/efeitos dos fármacos , Doença das Coronárias/complicações , Digoxina/administração & dosagem , Quimioterapia Combinada , Teste de Esforço , Feminino , Furosemida/administração & dosagem , Bloqueio Cardíaco/tratamento farmacológico , Doenças das Valvas Cardíacas/complicações , Ventrículos do Coração/efeitos dos fármacos , Humanos , Isossorbida/administração & dosagem , Masculino , Pessoa de Meia-Idade , Nifedipino/administração & dosagem , Taquicardia/tratamento farmacológico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA